Press release
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Insights and Sales Trends 2024
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market SizeThe global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market size is expected to reach US$ 3978.7 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-3C7231/Global_Methicillin_Resistant_Staphylococcus_Aureus_MRSA_Drugs_Market_Insights_and_Forecast_to_2028
The market is mainly driven by the significant applications of Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market. Bactrim, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vancomycin segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market, driven by demand from China, the second largest economy with some signs of stabilising, the Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Key Companies:
• Takeda Pharmaceutical
• Merck
• AstraZeneca
• GlaxoSmithKline
• Pfizer
• Cubist Pharmaceuticals
• ViroPharma
• Forest Laboratories
• Theravance
By Type
• Bactrim
• Vancomycin
• Clindamycin
• Minocycline
By Application
• Hospital
• Clinic
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-3C7231/global-methicillin-resistant-staphylococcus-aureus-mrsa-drugs
Email Id:
Please reach us at sales@valuates.com
Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Insights and Sales Trends 2024 here
News-ID: 3489368 • Views: …
More Releases from Valuates Reports
AI-powered ESG Reporting Software Market Revenue Share, Insights & Future Outloo …
AI-powered ESG Reporting Software Market Size
The global market for AI-powered ESG Reporting Software was valued at US$ 841 million in the year 2024 and is projected to reach a revised size of US$ 2524 million by 2031, growing at a CAGR of 17.0% during the forecast period.
North American market for AI-powered ESG Reporting Software is estimated to increase from $ million in 2024 to reach $ million by 2031, at…
Electric & Hydraulic Wellhead Drives for Onshore Market Revenue Share, Insights …
Electric & Hydraulic Wellhead Drives for Onshore Market
The global market for Electric & Hydraulic Wellhead Drives for Onshore was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A wellhead is the component at the surface of an oil or gas well that provides the structural and pressure-containing interface for…
All Flash Network Attached Storage (NAS) Market Revenue Share, Insights & Future …
All Flash Network Attached Storage (NAS) Market
The global market for All Flash Network Attached Storage (NAS) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Network additional storage is the name of a specialized data storage technology that can be directly connected to the computer network, providing centralized data…
Portable Normal Pressure Fire Fighting Pump for Industrial Market Revenue Share, …
Portable Normal Pressure Fire Fighting Pump for Industrial Market Size
The global market for Portable Normal Pressure Fire Fighting Pump for Industrial was valued at US$ 132 million in the year 2024 and is projected to reach a revised size of US$ 186 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Download Free Data: https://reports.valuates.com/request/sample/QYRE-Auto-34T15717/Global_Portable_Normal_Pressure_Fire_Fighting_Pump_for_Industrial_Market_Research_Report_2023?utm_source=Openpr&utm_medium=Referral
Report Scope
This report aims to provide a comprehensive presentation of the global market…
More Releases for Staphylococcus
Rise In Prevalence Of Methicillin-Resistant Staphylococcus Aureus Infections: Po …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Through 2025?
In recent times, the market size of drugs for methicillin-resistant staphylococcus aureus (MRSA) has seen continuous growth. The market, which was worth $2.35 billion in 2024, is projected to expand to $2.47 billion in…
Leading Growth Driver in the Methicillin-Resistant Staphylococcus Aureus (MRSA) …
What market dynamics are playing a key role in accelerating the growth of the methicillin-resistant staphylococcus aureus (mrsa) drugs market?
The growth of the methicillin-resistant Staphylococcus aureus drugs market is expected to be fuelled by the rise in Hospital Acquired Infections (HAIs). Patients acquire these infections while being treated at a healthcare center, usually 48 hours or more post admissions. The root causes behind HAIs include contaminated medical apparatus, lax hand…
Staphylococcus Aureus Testing Market In-Depth Market Research Report 2027
A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus…
Methicillin-resistant Staphylococcus Aureus Therapeutics Pipeline Analysis 2018
MRSA infection caused by specific "staph" bacteria that is often resistant to most of antibiotic treatments. S. aureus (SA) is listed as a ‘superbug’ by U.S. Centers for Disease Control and Prevention (CDC). MRSA can either be present harmlessly on the skin (colonization) or enter the body (e.g. through broken skin) and cause an infection. The study analyzed that MRSA infection therapeutics pipeline comprises approximately 52 drug candidates in different…
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Driver
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a type of staphylococcus aureus, which became resistant to methicillin, amoxicillin, penicillin, oxacillin, and other such commonly used antibiotics. Staphylococcus aureus harbors on the skin and nasal passage of about one third of the world population, which comprises around 33%, as per Centers for Disease Control and Prevention (CDC) review 2015. MRSA can be classified into two types, based on mode of infection – Hospital…
Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Maufacturing Cos …
Qyresearchreports include new market research report "Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size, Status and Forecast 2022" to its huge collection of research reports.
The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market is exhibiting steady growth amidst a dynamic business environment. The report is compiled to identify key growth avenues of the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market and challenges that pose threat to its expansion goals. It also…
